KCT0006901
Recruiting
未知
Seroprevalence of anti-SARS-CoV-2 antibody in response to COVID-19 vaccine in patients with i nflammatory bowel disease SARS-CoV-2
Keimyung University Dongsan Hospital0 sites150 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Keimyung University Dongsan Hospital
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who are scheduled to receive SARS\-CoV\-2 vaccine (BNT162b2, mRNA\-1273\) among IBD patients aged 20 to 80 years
- •2\. Patients who are expected to complete SARS\-CoV\-2 vaccination among IBD patients aged 20 to 80 years
- •3\. A person who has signed a written consent form after agreeing to the purpose and method of the clinical research
- •4\. Patients taking 5\-aminosalicylic acid (ASA), immunomodulatory agents, or biological agents (infliximab or vedolizumab) among Crohn's disease/ulcerative colitis patients
Exclusion Criteria
- •1\. Patients with IBD for whom information on adverse reactions related to vaccination cannot be obtained
- •2\. Patients with acute illness who have been hospitalized within 4 weeks of starting vaccination
- •3\. Patients who have had surgery within 3 months
- •4\. Those who have passed more than 19 weeks after completing the second dose of vaccine
- •5\. Subjects who do not agree to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Prevalence of COVID19 antibodies among blood donors.CTRI/2021/01/030455ivetha M
Completed
Not Applicable
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers with differing risk of exposureCOVID-1910047438NL-OMON49447niversitair Medisch Centrum Groningen600
Recruiting
Not Applicable
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in LeipzigU07.1COVID-19, virus identifiedDRKS00023364Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig2,000
Completed
Not Applicable
Seroprevalence of SARS-CoV-2 antibodies in a quarantined community after a COVID-19 outbreak-the CoNAN study07.1 COVID-19DRKS00022416niversitätsklinikum Jena626
Recruiting
Not Applicable
Changes in anti-SARS-CoV-2 antibody levels in response to COVID-19 vaccinatioDiseases of the digestive systemKCT0007311Keimyung University Dongsan Hospital200